SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-22-023321
Filing Date
2022-06-16
Accepted
2022-06-16 20:52:18
Documents
2
Period of Report
2022-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3737
2 EXHIBIT 24 brhc10038846_ex24.htm EX-24 10142
  Complete submission text file 0001140361-22-023321.txt   15491
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Issuer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address AMGEN INC. ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address
BEIER DAVID W (Reporting) CIK: 0001187054 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-31141 | Film No.: 221022199